DaVita Inc. (DVA): Price and Financial Metrics

DaVita Inc. (DVA): $132.74

1.17 (-0.87%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

B

Add DVA to Watchlist
Sign Up

Industry: Medical - Services

Industry

C

Ranked

#6 of 66

in industry

DVA Price/Volume Stats

Current price $132.74 52-week high $141.54
Prev. close $133.91 52-week low $71.51
Day low $132.73 Volume 472,800
Day high $134.29 Avg. volume 806,173
50-day MA $131.17 Dividend yield N/A
200-day MA $107.15 Market Cap 11.64B

DVA Stock Price Chart Interactive Chart >


DaVita Inc. (DVA) Company Bio


DaVita Inc. provides kidney dialysis services through a network of 2,816 outpatient dialysis centers in the United States, serving 204,200 patients, and 321 outpatient dialysis centers in 10 other countries serving 3,200 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives unless they receive a donor kidney. The company has a 37% market share in the U.S. dialysis market. It is organized in Delaware and based in Denver. (Source:Wikipedia)


DVA Latest News Stream


Event/Time News Detail
Loading, please wait...

DVA Latest Social Stream


Loading social stream, please wait...

View Full DVA Social Stream

Latest DVA News From Around the Web

Below are the latest news stories about DAVITA INC that investors may wish to consider to help them evaluate DVA as an investment opportunity.

Brookdale (BKD) Concludes Transactions to Extend Debt Repayment

Brookdale (BKD) completes two financing transactions to push its debt maturities until September 2025, thereby relieving it from the debt repayment burden for next year and focusing on core operations.

Yahoo | December 28, 2023

3 Reasons to Hold Zimmer Biomet (ZBH) Stock in Your Portfolio

Zimmer Biomet's (ZBH) focus on emerging markets raises optimism about the stock.

Yahoo | December 28, 2023

Three Reasons to Add Ecolab (ECL) Stock to Your Portfolio

Ecolab's (ECL) focus on R&D raises optimism about the stock.

Yahoo | December 28, 2023

The Zacks Analyst Blog Highlights DaVita, GE HealthCare Technologies and Hologic

DaVita, GE HealthCare Technologies and Hologic are part of the Zacks top Analyst Blog.

Yahoo | December 28, 2023

DVA vs. CHE: Which Stock Is the Better Value Option?

DVA vs. CHE: Which Stock Is the Better Value Option?

Yahoo | December 27, 2023

Read More 'DVA' Stories Here

DVA Price Returns

1-mo -1.86%
3-mo 23.86%
6-mo 72.91%
1-year 53.87%
3-year 17.11%
5-year 138.70%
YTD 26.71%
2023 40.30%
2022 -34.36%
2021 -3.10%
2020 56.47%
2019 45.80%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!